DETAILED NOTES ON SUVOREXANT

Coadministration with CYP3A4 substrates, significantly Those people with a slender therapeutic index, may result in lessened concentrations and loss of efficacy. If struggling to stay clear of coadministration, observe CYP3A4 substrate degrees and change dose as needed.This information and facts from Lexicomp® clarifies what you need to know conce